BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25125080)

  • 1. Recent advances in the discovery of N-myristoyltransferase inhibitors.
    Zhao C; Ma S
    ChemMedChem; 2014 Nov; 9(11):2425-37. PubMed ID: 25125080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-myristoyltransferase: a novel target.
    Prasad KK; Toraskar MP; Kadam VJ
    Mini Rev Med Chem; 2008 Feb; 8(2):142-9. PubMed ID: 18289097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of N-myristoyltransferase from Aspergillus fumigatus.
    Shimada T; Suzuki M; Katakura S
    Acta Crystallogr D Biol Crystallogr; 2015 Apr; 71(Pt 4):754-61. PubMed ID: 25849386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of protein N-myristoylation: a therapeutic protocol in developing anticancer agents.
    Das U; Kumar S; Dimmock JR; Sharma RK
    Curr Cancer Drug Targets; 2012 Jul; 12(6):667-92. PubMed ID: 22463587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: protein N-myristoyltransferase.
    Lodge JK; Jackson-Machelski E; Devadas B; Zupec ME; Getman DP; Kishore N; Freeman SK; McWherter CA; Sikorski JA; Gordon JI
    Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():357-366. PubMed ID: 9043113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.
    Sikorski JA; Devadas B; Zupec ME; Freeman SK; Brown DL; Lu HF; Nagarajan S; Mehta PP; Wade AC; Kishore NS; Bryant ML; Getman DP; McWherter CA; Gordon JI
    Biopolymers; 1997; 43(1):43-71. PubMed ID: 9174411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclohexyl-octahydro-pyrrolo[1,2-a]pyrazine-based inhibitors of human N-myristoyltransferase-1.
    French KJ; Zhuang Y; Schrecengost RS; Copper JE; Xia Z; Smith CD
    J Pharmacol Exp Ther; 2004 Apr; 309(1):340-7. PubMed ID: 14724220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian myristoyl CoA: protein N-myristoyltransferase.
    Raju RV; Magnuson BA; Sharma RK
    Mol Cell Biochem; 1995; 149-150():191-202. PubMed ID: 8569729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of Candida albicans N-myristoyltransferase with two distinct inhibitors.
    Sogabe S; Masubuchi M; Sakata K; Fukami TA; Morikami K; Shiratori Y; Ebiike H; Kawasaki K; Aoki Y; Shimma N; D'Arcy A; Winkler FK; Banner DW; Ohtsuka T
    Chem Biol; 2002 Oct; 9(10):1119-28. PubMed ID: 12401496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of N-myristoyltransferase in cancer.
    Selvakumar P; Lakshmikuttyamma A; Shrivastav A; Das SB; Dimmock JR; Sharma RK
    Prog Lipid Res; 2007 Jan; 46(1):1-36. PubMed ID: 16846646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from protozoan parasites: active site characterization and insights into rational inhibitor design.
    Sheng C; Ji H; Miao Z; Che X; Yao J; Wang W; Dong G; Guo W; Lü J; Zhang W
    J Comput Aided Mol Des; 2009 Jun; 23(6):375-89. PubMed ID: 19370313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myristoyl-coA:protein N-myristoyltransferase from bovine cardiac muscle: molecular cloning, kinetic analysis, and in vitro proteolytic cleavage by m-calpain.
    Raju RV; Kakkar R; Datla RS; Radhi J; Sharma RK
    Exp Cell Res; 1998 May; 241(1):23-35. PubMed ID: 9633510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myristoyl-CoA:protein N-myristoyltransferase: a novel molecular approach for cancer therapy (Review).
    Selvakumar P; Pasha MK; Ashakumary L; Dimmock JR; Sharma RK
    Int J Mol Med; 2002 Oct; 10(4):493-500. PubMed ID: 12239600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel inhibitor protein of N-myristoyltransferase from Escherichia coli.
    Gowda S; Shrivastav A; Selvakumar P; Dimmock JR; Sharma RK
    Biochem Biophys Res Commun; 2004 Feb; 314(4):984-7. PubMed ID: 14751229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of bovine brain N-myristoyltransferase(s) by a cytosolic activator.
    King MJ; Sharma RK
    Biochem Biophys Res Commun; 1995 Jul; 212(2):580-8. PubMed ID: 7626073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungals targeted to protein modification: focus on protein N-myristoyltransferase.
    Georgopapadakou NH
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1117-25. PubMed ID: 12150705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal N-myristoylation of proteins: refinement of the sequence motif and its taxon-specific differences.
    Maurer-Stroh S; Eisenhaber B; Eisenhaber F
    J Mol Biol; 2002 Apr; 317(4):523-40. PubMed ID: 11955007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myristoyl CoA:protein N-myristoyltransferase: subcellular localization, activation and kinetic behavior in the presence of organic solvents.
    Rajala RV; Sharma RK
    Biochem Biophys Res Commun; 1995 Mar; 208(2):617-23. PubMed ID: 7695615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of myristoyl CoA analogues and myristoyl peptides as inhibitors of myristoyl CoA:protein N-myristoyltransferase.
    Zheng GQ; Hu X; Cassady JM; Paige LA; Geahlen RL
    J Pharm Sci; 1994 Feb; 83(2):233-8. PubMed ID: 8169796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.